Anti BRD4 pAb (ATL-HPA061646)

Catalog No:
ATL-HPA061646-25
$360.00
Application: ICC, IHC 
Clonality: Polyclonal 
Host: Rabbit 
Reactivity: Human 
Protein Description: bromodomain containing 4
Gene Name: BRD4
Alternative Gene Name: CAP, HUNK1, HUNKI, MCAP
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000024002: 97%, ENSRNOG00000006770: 97%
Entrez Gene ID: 23476
Uniprot ID: O60885
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Cognate Antibody/Antigen for Anti BRD4 pAb (ATL-HPA061646)
Antigen PrEST Antigen BRD4 (ATL-APrEST87931)
Documents & Links for Anti BRD4 pAb (ATL-HPA061646)
Datasheet Anti BRD4 pAb (ATL-HPA061646) Datasheet (External Link)
Vendor Page Anti BRD4 pAb (ATL-HPA061646) at Atlas

Documents & Links for Anti BRD4 pAb (ATL-HPA061646)
Datasheet Anti BRD4 pAb (ATL-HPA061646) Datasheet (External Link)
Vendor Page Anti BRD4 pAb (ATL-HPA061646)

Citations for Anti BRD4 pAb (ATL-HPA061646) – 3 Found
Tumoral BRD4 expression in lymph node-negative breast cancer: association with T-bet+ tumor-infiltrating lymphocytes and disease-free survival.
BMC Cancer. 2018 Jul 20;18(1):750. doi: 10.1186/s12885-018-4653-6.  PubMed
miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein.
Sci Rep. 2018 Mar 14;8(1):4482. doi: 10.1038/s41598-018-22767-y.  PubMed
miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway.
Mol Ther. 2020 Jun 3;28(6):1494-1505. doi: 10.1016/j.ymthe.2020.04.001. Epub 2020 Apr 11.  PubMed